| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/03/2011 | US20110053835 Antimicrobial peptides derived from cap18 |
| 03/03/2011 | US20110053834 Novel antibiotic peptide derived from ribosomal protein l1 of helicobacter pylori and use thereof |
| 03/03/2011 | US20110053833 Synthetic peptides and their use |
| 03/03/2011 | US20110053832 Natural antimicrobial composition |
| 03/03/2011 | US20110053831 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith |
| 03/03/2011 | US20110053830 Methods for treating septic shock |
| 03/03/2011 | US20110053829 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
| 03/03/2011 | US20110053828 Use of Urea-Adjuvated Polypeptides for Diagnosis, Prophylaxis and Therapy |
| 03/03/2011 | US20110053827 Intranasal administration |
| 03/03/2011 | US20110053781 Methods and compositions for polypeptide engineering |
| 03/03/2011 | US20110053217 Polynucleotides encoding signal peptide-containing molecules |
| 03/03/2011 | US20110053182 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/03/2011 | US20110053137 Methods of modulating cold sensory perception |
| 03/03/2011 | US20110052729 Pharmaceutical or nutraceutical composition |
| 03/03/2011 | US20110052717 Slow release pharmaceutical composition made of microparticles |
| 03/03/2011 | US20110052715 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 03/03/2011 | US20110052711 Controlled release multidrug formulations for spinal cord injury |
| 03/03/2011 | US20110052709 Novel nanoparticles for delivery of active agents |
| 03/03/2011 | US20110052706 Pancreatine pellets and method of producing same |
| 03/03/2011 | US20110052702 Method and Apparatus for Producing Organic Nanotubes |
| 03/03/2011 | US20110052694 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles |
| 03/03/2011 | US20110052692 Novel hydrogels and uses thereof |
| 03/03/2011 | US20110052691 Sustained Release Systems and Preparation Method Thereof |
| 03/03/2011 | US20110052678 Method for treating age related macular degeneration |
| 03/03/2011 | US20110052677 Modulation of srpx2-mediated angiogenesis |
| 03/03/2011 | US20110052676 Composition For Delaying Cellular Senescence |
| 03/03/2011 | US20110052673 Therapeutic compositions |
| 03/03/2011 | US20110052663 Hemostatic Sponge with Enzyme and Method of Manufacture |
| 03/03/2011 | US20110052661 Pet dental hygiene product |
| 03/03/2011 | US20110052658 Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| 03/03/2011 | US20110052657 Implants for administering substances and methods of producing implants |
| 03/03/2011 | US20110052640 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies |
| 03/03/2011 | US20110052639 Allergen mutants |
| 03/03/2011 | US20110052637 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as vaccines |
| 03/03/2011 | US20110052625 Compositions and methods for treating diabetes using lisofylline analogs and islet neogenesis associated peptide |
| 03/03/2011 | US20110052617 Aav scleroprotein, production and use thereof |
| 03/03/2011 | US20110052616 Biological materials and uses thereof |
| 03/03/2011 | US20110052615 Tumour-specific animal proteins |
| 03/03/2011 | US20110052614 Stat3 epitope peptides |
| 03/03/2011 | US20110052613 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/03/2011 | US20110052603 method of treatment and agents useful for same |
| 03/03/2011 | US20110052602 Diagnosis and Treatment of Age Related Macular Degeneration |
| 03/03/2011 | US20110052599 Facilitation of Oocyte, Zygote and Pre-Implantation Embryo Maturation |
| 03/03/2011 | US20110052598 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 03/03/2011 | US20110052593 Breast cancer associated antigen |
| 03/03/2011 | US20110052590 Neutrokine-alpha antibodies and methods of use thereof |
| 03/03/2011 | US20110052588 Method of treating hepatocellular carcinoma |
| 03/03/2011 | US20110052584 Method of enhancement of cytotoxicity in antibody mediated immune responses |
| 03/03/2011 | US20110052577 Antibodies |
| 03/03/2011 | US20110052567 Methods Compositions, Uses, and Kits Useful for Vitamin D Deficiency and Related Disorders |
| 03/03/2011 | US20110052566 Cognitive function |
| 03/03/2011 | US20110052563 Gonadal function improving agents |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | US20110052561 Osteolysis treatment |
| 03/03/2011 | US20110052560 Method for Increasing the Activity of the Immune System of a Mammal at Risk of Inflammatory Diseases |
| 03/03/2011 | US20110052559 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| 03/03/2011 | US20110052558 Materials and methods for prevention and treatment of rna viral diseases |
| 03/03/2011 | US20110052557 Phytocomposition having antimicrobial activity |
| 03/03/2011 | US20110052556 Pharmaceutical composition comprising racetam and carnitine and process for its preparation |
| 03/03/2011 | US20110052536 Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection |
| 03/03/2011 | US20110052535 Compositions for treating an inflammatory autoimmune condition |
| 03/03/2011 | US20110052534 Imidazopyridazine Compounds for Treating Viral Infections |
| 03/03/2011 | US20110052533 Compositions and Methods for Cartilage Repair |
| 03/03/2011 | US20110052532 Pharmaceutical composition comprising a cytokine |
| 03/03/2011 | US20110052531 Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy |
| 03/03/2011 | US20110052530 Adoptive cell therapy with young t cells |
| 03/03/2011 | US20110052529 Methods and compositions for expanding t regulatory cells |
| 03/03/2011 | US20110052528 Neuroprotective macrocyclic compounds and methods for their use |
| 03/03/2011 | US20110052527 Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
| 03/03/2011 | US20110052526 Method and composition for neochondrogenesis |
| 03/03/2011 | US20110052525 Breaking Immunological Tolerance with a Genetically Encoded Unnatural Amino Acid |
| 03/03/2011 | US20110052519 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails |
| 03/03/2011 | US20110052517 Cosmetic Uses of Modified Stressed Yeast Extracts and Related Compositions |
| 03/03/2011 | US20110052514 Use of natural active substances in cosmetic or therapeutic compositions |
| 03/03/2011 | US20110052494 H-antigen binding polypeptides and methods of use |
| 03/03/2011 | US20110052493 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human box-a of hmgb1 to prevent and/or antagonize pathologies induced by hmgb1 |
| 03/03/2011 | US20110052489 Anti-CD19 Antibodies |
| 03/03/2011 | US20110052488 Methods For Treating, Diagnosing, and Monitoring Rheumatoid Arthritis |
| 03/03/2011 | DE202005021885U1 Hydroxyalkylstärke-Protein-Konjugate, durch reduktive Aminierung hergestellt A hydroxyalkyl starch protein conjugates prepared by reductive amination |
| 03/03/2011 | DE102009038210A1 Medicament, useful e.g. for treating diabetes, controlling fasting, postprandial or postabsorptive blood glucose concentration in diabetic patients and improving glucose tolerance, comprises insulin and glucagon-like peptide-1 agonist |
| 03/03/2011 | CA2809803A1 Stabilized melanocortin ligands |
| 03/03/2011 | CA2773133A1 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| 03/03/2011 | CA2772610A1 Sdf-1 delivery for treating ischemic tissue |
| 03/03/2011 | CA2772441A1 Use of a holotoxin to reduce endoplasmic reticulum-associated degradation of misfolded proteins |
| 03/03/2011 | CA2772204A1 Methods and compositions for the inhibition of transplant rejection |
| 03/03/2011 | CA2772199A1 B7-h4 fusion proteins and methods of use thereof |
| 03/03/2011 | CA2772094A1 Methods and compositions for preventing or treating ophthalmic conditions |
| 03/03/2011 | CA2772001A1 New endolysin obpgplys |
| 03/03/2011 | CA2771328A1 Cofactors for thrombin activation of factor vii and uses thereof |
| 03/03/2011 | CA2771215A1 Therapeutic preparation for rhinitis |
| 03/03/2011 | CA2770695A1 Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates |
| 03/03/2011 | CA2770338A1 Processes for preparing protease inhibitors of hepatitis c virus |
| 03/03/2011 | CA2769835A1 Glucagon-like peptide-1 receptor (glp-1r) agonists for treating autoimmune disorders |
| 03/03/2011 | CA2768651A1 Particulate composition and pharmaceutical composition containing the same |
| 03/02/2011 | EP2290104A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 03/02/2011 | EP2290103A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 03/02/2011 | EP2290083A1 Conserved neisserial antigens |
| 03/02/2011 | EP2290081A2 IL-17 homologous polypeptide and therapeutic uses thereof |
| 03/02/2011 | EP2290079A2 Neurotrophic factors |